CALCR
Calcitonin receptor
As of the edition of 20 October 2026, CALCR (calcitonin receptor, UniProt P30988) has 7 drugs tested at it and 8 companies on the list, 0 on route A and 2 on route B.
Sources: UniProt, ClinicalTrials.gov, ChEMBL, FDA Orange Book and Purple Book, Pharos.
The protein
- UniProt
- P30988
- How well studied
- Drug target: an approved drug acts on it
- Where it sits in the cell
- At a membrane
- Solved structures
- 32
- Disease areas
- Nutrition and metabolism; Hormones; Immune system; Bones, joints and muscles; Nervous system; Digestive system; Injuries; Mental health
- Registered trials of its drugs
- 64
Drugs at this target
| Status | Count |
|---|---|
| Marketed | 4 |
| Active | 1 |
| Went quiet | 2 |
| Total | 7 |
| Drug | Status | Furthest phase | US protection |
|---|---|---|---|
| Pramlintide | Marketed | Phase 4 | none listed |
| Calcitonin | Marketed | Phase 4 | none listed |
| Calcitonin salmon | Marketed | Phase 4 | none listed |
| Maltodextrin | Active | Phase 4 | none listed |
| Davalintide | Went quiet | Phase 2 | none listed |
| SMC021 | Went quiet | Phase 2 | none listed |
| Calcitonin human | Marketed | No phase stated | none listed |
7 of 7 drugs, the most tested first.
Companies at this target
| Where the company stands | Companies |
|---|---|
| Route B | 2 |
| Undetermined | 6 |
| Total on the list | 8 |
| Company | Route |
|---|---|
| AstraZeneca | Route B |
| Sanofi | Route B |
The other 6 companies at CALCR
In the product8 companies in all; 6 are not named here, and no score is.
See the 8 companies at CALCR, ranked, with the facts behind eachRequest access. Nothing is shown until you do.